Pharma Contract Manufacturing 2019: Post-Show Report
The manufacturing industry is booming, with outsourced manufacturing for pharma development rising to a value of $76 billion by 2030. However, alongside these developments, one of the most difficult challenges posed for the industry is managing ongoing communications and relationships between contract manufacturing organisations (CMO) to optimise external partners.
In light of these rapidly evolving pressures on managing external partnerships, quality, cost and scalability, Pharma IQ have created a post-show report highlighting the most exciting takeaways from the 2019 Pharma Contract Manufacturing Forum.
Download the full report on the right >>
Other key benefits to downloading the full report:
- An overview of the process pain points, with expert commentary on the critical gaps in our external manufacturing network and innovative solutions on how to fill them
- A summary of the key challenges in 2020 and the changes that need to be implemented across the industry in order to meet these challenges
- Key takeaways from the 2019 event
- What does the future hold for Pharma Contract Manufacturing – an overview of the 2020 event
Please note: That all fields marked with an asterisk (*) are required.